Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRY | TBPH | ESPR | ||
| Company | Ars Pharmaceuticals Inc | Theravance Bio Ord | Esperion Theraptc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.35 | 18.78 | 3.57 | ||
| High | 9.53 | 19.32 | 3.68 | ||
| Low | 9.30 | 18.77 | 3.52 | ||
| Latest | 9.45 | 19.17 | 3.57 | ||
| Change | +0.07 | +0.36 | +0.02 | ||
| % Change | +0.75% | +1.91% | +0.56% | ||
| Volume | 573,300 | 437,000 | 3,016,800 | ||
| 20-Day Average Volume | 1,284,315 | 406,540 | 4,200,370 | ||
| Previous Close | 9.38 | 18.81 | 3.55 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.93 | 19.67 | 3.38 | ||
| 20-Day Raw Stochastic | 37.00% | 27.91% | 86.06% | ||
| 20-Day Relative Strength | 44.74 | 49.57 | 53.30 | ||
| Weighted Alpha | -29.08 | +103.45 | +66.31 | ||
| Today's Opinion | 88% Sell | 80% Buy | 56% Buy | ||
| Previous Opinion | 72% Sell | 64% Buy | 56% Buy | ||
| Last Month's Opinion | 24% Sell | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.74% since 02/10/26 | -1.19% since 02/10/26 | +5.31% since 02/10/26 | ||
| Low | 8.61 on 02/13/26 | 18.45 on 02/11/26 | 3.33 on 02/11/26 | ||
| High | 9.94 on 02/11/26 | 20.40 on 02/17/26 | 3.68 on 02/18/26 | ||
| 1-Month | |||||
| %Chg | -11.10% since 01/16/26 | -4.20% since 01/16/26 | +17.43% since 01/16/26 | ||
| Low | 8.61 on 02/13/26 | 18.45 on 02/11/26 | 2.86 on 01/21/26 | ||
| High | 10.88 on 01/23/26 | 21.03 on 01/22/26 | 3.68 on 02/18/26 | ||
| 3-Month | |||||
| %Chg | +33.38% since 11/18/25 | +3.68% since 11/18/25 | +26.15% since 11/18/25 | ||
| Low | 6.66 on 11/21/25 | 17.25 on 12/17/25 | 2.73 on 11/19/25 | ||
| High | 13.15 on 01/12/26 | 21.03 on 01/22/26 | 4.18 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | -32.64% since 08/18/25 | +40.85% since 08/18/25 | +70.00% since 08/18/25 | ||
| Low | 6.66 on 11/21/25 | 13.25 on 08/19/25 | 2.00 on 08/20/25 | ||
| High | 15.09 on 08/21/25 | 21.03 on 01/22/26 | 4.18 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 927,204 | 953,140 | 848,674 | ||
| Shares Outstanding, K | 98,849 | 50,672 | 239,063 | ||
| Annual Sales | 89,150,000 | 64,380,000 | 332,310,000 | ||
| Annual Net Income | 8,000,000 | -56,420,000 | -51,750,000 | ||
| Last Quarter Sales | 32,500,000 | 19,990,000 | 87,310,000 | ||
| Last Quarter Net Income | -51,150,000 | 3,620,000 | -31,330,000 | ||
| 60-Month Beta | 0.79 | 0.15 | 1.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.52 on 11/10/25 | 0.04 on 11/10/25 | -0.16 on 11/06/25 | ||
| Latest Earnings Date | 03/19/26 | 02/25/26 | 03/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.55 | 0.00 | ||